Evidence map›Paper›PMID 30484014›Full record

Observational studySupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2019

Pre-to-post diagnosis weight trajectories in colorectal cancer patients with non-metastatic disease.

Moniek van Zutphen, Anouk Geelen, Hendriek C Boshuizen, Renate M Winkels, Anne J M R Geijsen, Evertine Wesselink, Merel Snellen, Dieuwertje E Kok, Johannes H W de Wilt, Paul C van de Meeberg and 5 more

Abstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Association of patient factors and health-related quality of life with weight changes during chemotherapy for colorectal cancer: secondary analysis of the SCOT trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  3. Article
  4. Article
  5. Article
  6. Weight Gain Among Cancer Patients Receiving Chemotherapy-Facts and Numbers.Journal of cachexia, sarcopenia and muscle · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Assessing the relationship between symptoms and health care utilization in colorectal cancer survivors of different sexual orientations.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Moniek van ZutphenDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands. moniek.vanzutphen@wur.nl.ORCID http://orcid.org/0000-0002-2368-0606
Anouk GeelenDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Hendriek C BoshuizenDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Renate M WinkelsDepartment Public Health Sciences, College of Medicine, Penn State University, Hershey, PA, USA.
Anne J M R GeijsenDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Evertine WesselinkDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Merel SnellenDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Dieuwertje E KokDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Johannes H W de WiltDepartment of Surgery, Radboud University Medical Centre, Geert Grooteplein-Zuid 22, 6525 GA, Nijmegen, The Netherlands.
Paul C van de MeebergDepartment of Gastroenterology, Slingeland Hospital, P.O. Box 169, 7000 AD, Doetinchem, The Netherlands.
Ewout A KouwenhovenDepartment of Surgery, Hospital Group Twente ZGT, Zilvermeeuw 1, 7609 PP, Almelo, The Netherlands.
Henk K van HalterenDepartment of Internal Medicine, Admiraal de Ruyter Ziekenhuis, 's-Gravenpolderseweg 114, 4462 RA, Goes, The Netherlands.
Ernst J Spillenaar BilgenDepartment of Surgery, Rijnstate Hospital, Wagnerlaan 55, 6815 AD, Arnhem, The Netherlands.
Ellen KampmanDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.
Fränzel J B van DuijnhovenDivision of Human Nutrition and Health, Wageningen University and Research, Stippeneng 4, 6708 WE, Wageningen, The Netherlands.

Funding

Alpe d'Huzes/Dutch Cancer Society UM 2012-5653Alpe d'Huzes/Dutch Cancer Society UW 2013-5927Alpe d'Huzes/Dutch Cancer Society UW 2015-7946ERA-NET on Translational Cancer Research (TRANSCAN/Dutch Cancer Society) UW2013-6397ERA-NET on Translational Cancer Research (TRANSCAN/Dutch Cancer Society) UW2014-6877Wereld Kanker Onderzoek Fonds 2014/1179
6 · The paper itself

Abstract

purposePrevious studies have shown that > 50% of colorectal cancer (CRC) patients treated with adjuvant chemotherapy gain weight after diagnosis. This may affect long-term health. Therefore, prevention of weight gain has been incorporated in oncological guidelines for CRC with a focus on patients that undergo adjuvant chemotherapy treatment. It is, however, unknown how changes in weight after diagnosis relate to weight before diagnosis and whether weight changes from pre-to-post diagnosis are restricted to chemotherapy treatment. We therefore examined pre-to-post diagnosis weight trajectories and compared them between those treated with and without adjuvant chemotherapy.

methodsWe included 1184 patients diagnosed with stages I-III CRC between 2010 and 2015 from an ongoing observational prospective study. At diagnosis, patients reported current weight and usual weight 2 years before diagnosis. In the 2 years following diagnosis, weight was self-reported repeatedly. We used linear mixed models to analyse weight trajectories.

resultsMean pre-to-post diagnosis weight change was -0.8 (95% CI -1.1, -0.4) kg. Post-diagnosis weight gain was + 3.5 (95% CI 2.7, 4.3) kg in patients who had lost ≥ 5% weight before diagnosis, while on average clinically relevant weight gain after diagnosis was absent in the groups without pre-diagnosis weight loss. Pre-to-post diagnosis weight change was similar in patients treated with (-0.1 kg (95%CI -0.8, 0.6)) and without adjuvant chemotherapy (-0.9 kg (95%CI -1.4, -0.5)).

conclusionsOverall, hardly any pre-to-post diagnosis weight change was observed among CRC patients, because post-diagnosis weight gain was mainly observed in patients who lost weight before diagnosis. This was observed independent of treatment with adjuvant chemotherapy.

Indexed as

Body-Weight TrajectoryAgedBody WeightChemotherapy, AdjuvantColorectal NeoplasmsDisease ProgressionFemaleHumansMaleMiddle AgedNetherlandsWeight GainWeight LossChemotherapyColorectal cancerWeight changeWeight gain

Identifiers

PMID30484014
PMCPMC6394719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.